Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/185030
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Catalyzing transcriptomics research in cardiovascular disease: the CardioRNA COST action CA17129 |
Autor: | Pedrosa da Costa Gomes, Clarissa; Ágg, Bence; Andova, Andrejaana; Arslan, Serdal; Baker, Andrew; Barteková, Monika; Beis, Dimitris; Betsou, Fay; Bezzina Wettinger, Stephanie; Bugarski, Branko; Condorelli, Gianluigi; Silva, Gustavo José Justo da; Danilin, Sabrina; Gonzalo-Calvo, David de CSIC ORCID; Buil, Alfonso; Carmo-Fonseca, Maria; Enguita, Francisco J.; Felekkis, Kyriacos; Ferdinandy, Peter; Gyöngyösi, Mariann; Hackl, Matthias; Karaduzovic-Hadziabdic, Kanita; Hellemans, Jan; Heymans, Stephane; Hlavackova, Markéta; Hoydal, Morten Andre; Jankovic, Aleksandra; Jusic, Amela; Kardassis, Dimitris; Kerkelä, Risto; Kuster, Gabriela M.; Lakkisto, Päivi; Leszek, Przemyslaw; Lustrek, Mitja; Maegdefessel, Lars; Martelli, Fabio; Novella, Susana; O’Brien, Timothy; Papaneophytou, Christos; Pedrazzini, Thierry; Pinet, Florence; Popescu, Octavian; Potočnjak, Ines; Robinson, Emma; Sasson, Shlomo; Scholz, Markus; Simionescu, Maya; Stoll, Monika; Varga, Zoltan V.; Vinciguerra, Manlio; Xuereb, Angela; Yilmaz, Mehmet Birhan; Emanueli, Costanza; Devaux, Yvan | Palabras clave: | Cardiovascular disease Transcriptomics Best practices and guidelines Translational research Personalized medicine |
Fecha de publicación: | 29-mar-2019 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Non-Coding RNA 5(2): 31 (2019) | Resumen: | Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu). | Versión del editor: | https://doi.org/10.3390/ncrna5020031 | URI: | http://hdl.handle.net/10261/185030 | DOI: | 10.3390/ncrna5020031 |
Aparece en las colecciones: | (IIBB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
catalyzing_transcriptomics_research_cardiovascular_disease.pdf | 1,11 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
10
checked on 30-mar-2024
WEB OF SCIENCETM
Citations
9
checked on 27-feb-2024
Page view(s)
291
checked on 18-abr-2024
Download(s)
154
checked on 18-abr-2024